MEDICAL COMMUNITY

Migraine at work: The stamp that changes it all

EMHA launches the first Migraine Friendly Workplace Stamp. This new initiative is designed to reduce the impact of migraine in the workplaceand recognizes companies that undertake EMHA training as well as making actionablechange in the workplace. Migraine affects over 41 million adults in Europe (prevalence 14%)1 and as migraine peaksduring individuals’ most productive years of …

Migraine at work: The stamp that changes it all Read More »

New e-learning series on Personalized Healthcare

As part of EFNA’s Training Initiatives for Neurology Advocates [TINA] programme, a new series of e-learning modules is launched today, on the theme of personalised healthcare. Personalised medicine is a medical model that aims to provide tailor-made prevention and treatment strategies for defined groups of individuals. This usually involves genomics, information technology and patient empowerment. However, at EFNA, we feel …

New e-learning series on Personalized Healthcare Read More »

Essentials: A series of interviews by AEMICE

Within the documentary ‘Essentials: The role of patients’ associations in the health and social system in the COVID era’ we present a series of interviews with the associations. In this interview, AEMICE talks with Elena Ruiz de la Torre on the importance of the patient’s role in the health system. “We have been in quarantine …

Essentials: A series of interviews by AEMICE Read More »

Chronic Migraine is officially regulated as a social disease in Italy

The Italian senate has approved the recognition of primary chronic headache as a social disease,  a huge step towards the acknowledgment of migraine as the serious illness it is. On April 18, 2019 the Chamber passed the bill and 15 months later it was finally approved by the Italian Senate. This achievement reflects the struggle …

Chronic Migraine is officially regulated as a social disease in Italy Read More »

Read the latest publications by EMHA on Migraine At Work

All the articles are based on the survey led by EMHA on Migraine at work. Read the survey on the following link to find out more about the study: https://www.emhalliance.org/wp-content/uploads/2020/01/EMHA-Migraine-at-work.pdf SEMERGEN publication European Survey on preventive treatments on migraine Medicina Balear Magazine EMHA at Work: SED Publication Survey

Covid-19 & migraine and other headaches: Webinar by Vall d’Hebron

Watch the first webinar for patients on Covid-19 and its impact on migraine and other headaches streamed by Vall d’Hebron Hospital with the support of EMHA.

Learn about the impact of the virus on patients with migraine, the possible risks associated with the treatments and advice on reducing the negative  impact of the lock down during migraine and other headaches episodes.

Scroll to Top